Document is current
Any future updates will be listed below
-
Authors
Glenthøj, Andreas https://orcid.org/0000-0003-2082-0738
Rasmussen, Andreas Ørslev
Bendtsen, Selma Kofoed
Hasle, Henrik
Hoffmann, Marianne
Rieneck, Klaus
Dziegiel, Morten Hanefeld
Sjö, Lene Dissing
Frederiksen, Henrik
Hansen, Dennis Lund
Fassi, Daniel El
Rathe, Mathias
Jensen, Peter-Diedrich Matthias
Winther-Larsen, Anne
Nielsen, Christian
Olsen, Marianne
Toft, Nina
Lorenzen, Mads Okkels Birk
Jensen, Lise Heilmann
Gudbrandsdottir, Sif
Helby, Jens
Rossing, Maria
van Wijk, Richard
Petersen, Jesper
-
Funding
Funding for this research was provided by:
Copenhagen University
- License Information
-
More Information
Article History
Received: 5 September 2023
Accepted: 26 July 2024
First Online: 31 July 2024
Declarations
:
: Human Ethics and Consent to Participate declarationsThe study is performed in accordance with approval from the Ethical Committee of the Capital Region of Denmark (H-21064560) and the Danish Data Protection Agency (P-2021-736). Patients provide informed consent to participate.
: Patients provide informed consent, including consent for publication.
: During the preparation of this work, the authors used OpenAI’s language model, GPT-4 in order to improve language and readability. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.
: The authors declare the following conflicts of interest: M. Hoffmann (Consultancy: Roche, Vertex; Research Support: Pfizer), H. Frederiksen (Research funding outside this study: Sanofi), D.L. Hansen (Research grants outside this study from Alexion and Novartis, and advisory board for Takeda and Janssen), S. Gudbrandsdottir (Consultancy: SOBI), R. van Wijk (Research support: Agios Pharmaceuticals, Inc and Pfizer; Consultancy: Agios), A. Glenthøj (Consultancy: Agios, bluebird bio, Novo Nordisk, Bristol Myers Squibb, Novartis, Pharmacosmos; Research support: Novo Nordisk, Saniona, Sanofi), M. Rossing (Consultancy: AstraZeneca, MSD, GSK; Research Support: Novo Nordisk Fonden, Neye Fonden). All other authors declare no conflicts of interest.
